A multi-centre phase IIa clinical study of predictive testing for preeclampsia: improved pregnancy outcomes via early detection (IMPROvED)

نویسندگان

  • Kate Navaratnam
  • Zarko Alfirevic
  • Philip N Baker
  • Christian Gluud
  • Berthold Grüttner
  • Karolina Kublickiene
  • Gerda Zeeman
  • Louise C Kenny
چکیده

BACKGROUND 5% of first time pregnancies are complicated by pre-eclampsia, the leading cause of maternal death in Europe. No clinically useful screening test exists; consequentially clinicians are unable to offer targeted surveillance or preventative strategies. IMPROvED Consortium members have pioneered a personalised medicine approach to identifying blood-borne biomarkers through recent technological advancements, involving mapping of the blood metabolome and proteome. The key objective is to develop a sensitive, specific, high-throughput and economically viable early pregnancy screening test for pre-eclampsia. METHODS/DESIGN We report the design of a multicentre, phase IIa clinical study aiming to recruit 5000 low risk primiparous women to assess and refine innovative prototype tests based on emerging metabolomic and proteomic technologies. Participation involves maternal phlebotomy at 15 and 20 weeks' gestation, with optional testing and biobanking at 11 and 34 weeks. Blood samples will be analysed using two innovative, proprietary prototype platforms; one metabolomic based and one proteomic based, both of which outperform current biomarker based screening tests at comparable gestations. Analytical and clinical data will be collated and analysed via the Copenhagen Trials Unit. DISCUSSION The IMPROvED study is expected to refine proteomic and metabolomic panels, combined with clinical parameters, and evaluate clinical applicability as an early pregnancy predictive test for pre-eclampsia. If 'at risk' patients can be identified, this will allow stratified care with personalised fetal and maternal surveillance, early diagnosis, timely intervention, and significant health economic savings. The IMPROvED biobank will be accessible to the European scientific community for high quality research into the cause and prevention of adverse pregnancy outcome. TRIAL REGISTRATION Trial registration number NCT01891240The IMPROvED project is funded by the seventh framework programme for Research and Technological development of the EU. http://www.fp7-improved.eu/

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The Role of Uterine Artery Doppler Ultrasound in the Second Trimester in Predicting Preeclampsia

Background Preeclampsia is a specific pregnancy syndrome. Early diagnosis and proper administration of preeclampsia can lead to improved maternal and neonatal outcome. We aimed to investigate the uterine artery Doppler ultrasound in predicting the preeclampsia in women with a high-risk pregnancy. Materials and Methods This analytic study was conducted on 160 primigravida women with gestational...

متن کامل

What affects the outcome of severe preeclampsia?

Preeclampsia is a severe multi-system pregnancy related disorder associated with multiple maternal and fetal adverse outcomes, including fetal and maternal mortality. The aim of this study is to investigate the clinical difference between earlyand late-onset preeclampsia and their impact to perinatal outcome, and to detect possible antenatal parameters that can predict adverse fetal and materna...

متن کامل

Committee Opinion No. 638: First-Trimester Risk Assessment for Early-Onset Preeclampsia.

Hypertensive disorders with adverse sequelae (including preterm birth, maternal morbidity and mortality, and long-term risk of maternal cardiovascular disease) complicate 5-10% of pregnancies. Early identification of pregnant women at risk of developing early-onset preeclampsia would theoretically allow referral for more intensive surveillance or application of preventive therapies to reduce th...

متن کامل

Pnm-26: The Association Between Maternal Body Mass Index During First Trimester of Pregnancy with Preeclampsia

Background: Preeclampsia is the most important problems in pregnancy that irreparable complications for mother and fetus has. Maternal body mass index in the first trimester of pregnancy and weight gain during pregnancy is important in pregnancy outcome. This study to determine the association BMI first trimester mothers with preeclampsia have been done Materials and Methods: In this prospectiv...

متن کامل

سطح سرمی اسیداوریک و پی آمدهای آن در زنان حامله طبیعی و پراکلامپتیک

Background and purpose: Preeclampsia is a hypertensive disorder in pregnancy and is known as a specific syndrom of pregnancy. Several studies have been done to asses the indicators of preeclampsia for early detection of the disease. Uric acid is considered by some investigators as one of the most sensetive indicators in preeclampsia. In contrast some researchers have found it not useful in pr...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 13  شماره 

صفحات  -

تاریخ انتشار 2013